SEC Filing Details

SEC Filing Details

Document Details

Form
424B1
Filing Date
Feb 11, 2011
Document Date
Feb 11, 2011
Form Description
Form of prospectus that discloses information previously omitted from the prospectus
Filing Group
Registration Statements
Company
ReShape Lifesciences
Issuer
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE